Shandong Buchang Pharmaceuticals Co Ltd

Shandong Buchang Pharmaceuticals Co Ltd

  • Price (CNY)19.23
  • Today's Change-0.49 / -2.48%
  • Shares traded7.03m
  • 1 Year change-8.19%
  • Beta--
Data delayed at least 15 minutes, as of Sep 23 2019 08:00 BST.
More ▼

Profile data is unavailable for this security.

About the company

SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. is a China-based company principally engaged in the research, development, manufacture and distribution of Chinese patent medicines. The Company’s main products are compound traditional Chinese medicines, including cerecarton capsules,wenxin granules, as well as danhong injections, among others. Its products are mainly applied to the fields of cardio-cerebrovascular diseases and gynecological diseases. The Company distributes its products within domestic market and to overseas markets, with North China, East China and Central China as its major markets.

  • Revenue in CNY (TTM)14.32bn
  • Net income in CNY1.99bn
  • Incorporated2001
  • Employees8.00k
  • Location
    Shandong Buchang Pharmaceuticals Co LtdNo. 369, Zhonghua West RoadHEZE 274009ChinaCHN
  • Phone+86 5 305299167
  • Fax+86 5 305299286
  • Websitehttp://www.buchang.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
Shanghai Hepu Medical Technology Co LtdAnnounced13 Sep 201913 Sep 2019Announced--20.26m
Chongqing Yijitang Biological Products Co LtdDeal completed23 Jan 201923 Jan 2019Deal completed--7.29m
Chongqing Hantong Biotechnology Co LtdDeal completed23 Jan 201923 Jan 2019Deal completed--2.12m

Institutional shareholders

2.35%Per cent of shares held by top holders
HolderShares% Held
China Asset Management Co., Ltd.as of 16 May 20192.28m0.42%
Huatai-PineBridge Fund Management Co., Ltd.as of 31 Dec 20181.95m0.36%
GF Fund Management Co., Ltd.as of 31 Dec 20181.79m0.33%
HuaAn Fund Management Co., Ltd.as of 31 Dec 20181.45m0.27%
Harvest Fund Management Co., Ltd.as of 06 Sep 20191.18m0.22%
Guotai Asset Management Co., Ltd.as of 31 Dec 20181.16m0.21%
E Fund Management Co., Ltd.as of 31 Dec 2018854.86k0.16%
Robeco Institutional Asset Management BVas of 31 Jul 2019849.76k0.16%
Harvest Global Investments Ltd.as of 05 Sep 2019640.72k0.12%
BlackRock Advisors (UK) Ltd.as of 05 Sep 2019605.99k0.11%
More ▼
Data from 31 Dec 2018 - 19 Sep 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.